Organigram Global

Organigram Global has established itself as a leading Canadian and international producer of high-quality indoor-grown cannabis for both medical and adult recreational markets. The company has pioneered innovation in product development—most notably with its patent-pending FAST™ nanoemulsion technology that enables faster onset and improved bioavailability of cannabinoids in ingestible products. A recent clinical pharmacokinetic study demonstrated up to ~50% faster onset and double the cannabinoid delivery at peak compared to traditional edibles. The company’s diversified brand portfolio leads several categories in Canada by market share following its acquisition of Motif Labs Ltd., which strengthened its position especially in vapes and infused pre-rolls. Internationally, it exports to Europe, Australia, UK, Germany, among others.